Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Retinal Imaging prevention and early detection of chronic diseases

Obiettivo

"""The World Health Organization (WHO) in its “Global status report on noncommunicable diseases 2014” shows that the impact of noncommunicable diseases (NCDs), also known as chronic diseases, is steadily growing. NCDs are the leading cause of death globally (68% of all deaths in 2012). The 4 main types of NCDs are cardiovascular (CVD) diseases (like cerebrovascular accidents or strokes and heart attacks), cancers, chronic respiratory diseases and diabetes. Cardiovascular diseases account for most NCD deaths (17.5 million people annually), followed by cancers (8.2 million), respiratory diseases (4 million), and diabetes (1.5 million).
This proposal addresses the prevention and early diagnosis of 2 types of NCDs, Cardiovascular (CVD) diseases and diabetes, by providing health professionals a tool for automatic quantification of parameters of the retina and automatic detection of lesions of the retina, with capacity for prevention and/or early detection of various diseases.
ULMA Embedded Solutions (UES) has developed a non-invasive and cost-effective tool for Automatic evaluation of Retinal Imaging Biomarkers (ARIB), which can be used in public health interventions delivered through a primary health-care approach to strengthen early detection and timely treatment of various diseases. Evidence shows that such interventions are excellent economic investments because, if applied to patients early, can reduce the need for more expensive treatment. """

Campo scientifico (EuroSciVoc)

Programma(i)

Argomento(i)

Meccanismo di finanziamento

SME-1 - SME instrument phase 1

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) H2020-SMEInst-2014-2015

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

ULMA MEDICAL TECHNOLOGIES SL
Contributo netto dell'UE
€ 50 000,00
Indirizzo
GARAGALTZA AUZOA 51
20560 Onati
Spagna
PMI
Sì
Regione
Noreste País Vasco Gipuzkoa
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
€ 71 429,00